In the current pandemic environment, high derivatives volatility levels often associated with breaking news of medical and therapeutic developments, as well as the availability and scope of government relief, stimulus and economic reopening programs have raised special insider trading issues for traders and asset managers. This webinar identifies current key concerns of regulators and prosecutors, with a special focus on the types of relationships and non-public information that may be most vulnerable to abuse —and most scrutinized by the authorities. The panelists also discuss hypothetical trading scenarios that would risk attracting scrutiny from regulators and prosecutors in the current market conditions, and suggest certain risk mitigants especially adapted to the current situation.
